Sewoon Medical Co. Ltd (100700) - Total Assets
Based on the latest financial reports, Sewoon Medical Co. Ltd (100700) holds total assets worth ₩167.34 Billion KRW (≈ $113.40 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Sewoon Medical Co. Ltd (100700) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sewoon Medical Co. Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Sewoon Medical Co. Ltd's total assets have evolved over time, based on quarterly financial data. Explore Sewoon Medical Co. Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Sewoon Medical Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Sewoon Medical Co. Ltd's total assets of ₩167.34 Billion consist of 78.8% current assets and 21.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 59.2% |
| Accounts Receivable | ₩13.09 Billion | 8.0% |
| Inventory | ₩16.98 Billion | 10.4% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩925.72 Million | 0.6% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Sewoon Medical Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Sewoon Medical Co. Ltd (100700) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sewoon Medical Co. Ltd's current assets represent 78.8% of total assets in 2025, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 59.2% of total assets in 2025, up from 3.8% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 10.4% of total assets.
Sewoon Medical Co. Ltd Competitors by Total Assets
Key competitors of Sewoon Medical Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Elbit Med Tech
TA:EMTC
|
Israel | ILA25.53 Million |
|
InBody Co.Ltd
KQ:041830
|
Korea | ₩318.34 Billion |
|
Value Added Technology Co. Ltd
KQ:043150
|
Korea | ₩658.61 Billion |
|
i-SENS Inc
KQ:099190
|
Korea | ₩591.04 Billion |
|
INFINITT Healthcare Co. Ltd
KQ:071200
|
Korea | ₩229.14 Billion |
|
MEDIANA Co.Ltd
KQ:041920
|
Korea | ₩147.44 Billion |
|
Meta Biomed Co. Ltd
KQ:059210
|
Korea | ₩180.11 Billion |
|
CU Medical Systems Inc
KQ:115480
|
Korea | ₩99.66 Billion |
Sewoon Medical Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 12.66 | 13.11 | 10.45 |
| Quick Ratio | 11.04 | 11.16 | 8.15 |
| Cash Ratio | 0.00 | 9.60 | 5.70 |
| Working Capital | ₩121.52 Billion | ₩112.91 Billion | ₩68.16 Billion |
Sewoon Medical Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Sewoon Medical Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.60 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4.5% |
| Total Assets | ₩163.87 Billion |
| Market Capitalization | $67.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sewoon Medical Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Sewoon Medical Co. Ltd's assets grew by 4.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Sewoon Medical Co. Ltd (2011–2025)
The table below shows the annual total assets of Sewoon Medical Co. Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩163.87 Billion ≈ $111.05 Million |
+4.48% |
| 2024-12-31 | ₩156.85 Billion ≈ $106.29 Million |
+6.98% |
| 2023-12-31 | ₩146.61 Billion ≈ $99.36 Million |
+10.67% |
| 2022-12-31 | ₩132.48 Billion ≈ $89.78 Million |
+6.22% |
| 2021-12-31 | ₩124.72 Billion ≈ $84.52 Million |
+13.88% |
| 2020-12-31 | ₩109.53 Billion ≈ $74.22 Million |
+4.84% |
| 2019-12-31 | ₩104.47 Billion ≈ $70.80 Million |
+7.84% |
| 2018-12-31 | ₩96.87 Billion ≈ $65.65 Million |
+12.56% |
| 2017-12-31 | ₩86.06 Billion ≈ $58.32 Million |
+0.88% |
| 2016-12-31 | ₩85.31 Billion ≈ $57.81 Million |
+8.49% |
| 2015-12-31 | ₩78.64 Billion ≈ $53.29 Million |
+7.73% |
| 2014-12-31 | ₩73.00 Billion ≈ $49.47 Million |
+12.93% |
| 2013-12-31 | ₩64.64 Billion ≈ $43.81 Million |
+14.86% |
| 2012-12-31 | ₩56.28 Billion ≈ $38.14 Million |
+2.08% |
| 2011-12-31 | ₩55.13 Billion ≈ $37.36 Million |
-- |
About Sewoon Medical Co. Ltd
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical … Read more